Try our beta test site
5 studies found for:    ave5530
Show Display Options
Rank Status Study
1 Terminated Evaluation of Efficacy and Safety of AVE5530 in Patients With Primary Hypercholesterolemia
Condition: Hypercholesterolemia
Interventions: Drug: AVE5530;   Drug: Placebo
2 Terminated Evaluation of Safety and Efficacy of AVE5530 as add-on to Ongoing High Doses of Statins in Patients With Primary Severe Hypercholesterolemia
Condition: Hypercholesterolemia
Interventions: Drug: AVE5530;   Drug: Placebo
3 Terminated Evaluation of Safety and Efficacy of AVE5530 as add-on to Ongoing Statins in Patients With Primary Hypercholesterolemia
Condition: Hypercholesterolemia
Interventions: Drug: 25 mg/day AVE5530;   Drug: 50 mg/day AVE5530;   Drug: placebo
4 Terminated Evaluation of Efficacy and Safety of AVE5530 Co-administered With Atorvastatin in Primary Hypercholesterolemia
Condition: Hypercholesterolemia
Interventions: Drug: AVE5530;   Drug: atorvastatin;   Drug: placebo
5 Completed A Study Evaluating the Safety and Efficacy of AVE5530 (4 Weeks) in Patients With Mild to Moderate Hypercholesterolemia
Condition: Hypercholesterolemia
Interventions: Drug: AVE5530;   Drug: placebo;   Drug: ezetimibe

Study has passed its completion date and status has not been verified in more than two years.